跳转至内容
Merck
CN

850446P

Avanti

14:0-18:0 PC

Avanti Research - A Croda Brand

别名:

1-十四烷酰基-2-十八烷酰基-sn-甘油-3-磷酰胆碱;MSPC;PC(14:0/18:0)

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式(希尔记法):
C40H80NO8P
化学文摘社编号:
分子量:
734.04
MDL number:
UNSPSC Code:
51191904
NACRES:
NA.25
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


产品名称

14:0-18:0 PC, 1-myristoyl-2-stearoyl-sn-glycero-3-phosphocholine, powder

assay

>99% (TLC)

form

powder

packaging

pkg of 1 × 200 mg (850446P-200mg), pkg of 1 × 25 mg (850446P-25mg)

manufacturer/tradename

Avanti Research - A Croda Brand 850446P

lipid type

phospholipids
cardiolipins

shipped in

dry ice

storage temp.

−20°C

SMILES string

[O-]P(OCC[N+](C)(C)C)(OC[C@]([H])(OC(CCCCCCCCCCCCCCCCC)=O)COC(CCCCCCCCCCCCC)=O)=O

InChI

1S/C40H80NO8P/c1-6-8-10-12-14-16-18-19-20-21-23-25-27-29-31-33-40(43)49-38(37-48-50(44,45)47-35-34-41(3,4)5)36-46-39(42)32-30-28-26-24-22-17-15-13-11-9-7-2/h38H,6-37H2,1-5H3/t38-/m1/s1

InChI key

TYAQXZHDAGZOEO-KXQOOQHDSA-N

General description

磷脂酰胆碱(PC)是结肠′粘膜层最重要的成分之一。14:0-18:0 PC(1-肉豆蔻酰基-2-硬脂酰基-sn-甘油-3-磷酸胆碱)是具有长烷基侧链的不对称脂质。

Application

14:0-18:0 PC(1-肉豆蔻酰基-2-硬脂酰基-sn-甘油-3-磷酸胆碱)可用于:
  • 脂质双层,采用差示扫描量热法(DSC)研究其与d-赤型-N-棕榈酰基-鞘磷脂(16:0-SM)的混溶性,
  • 作为脂质体中的不对称脂质成分,研究双层面积和脂质几何形状的影响,并作为脂质体增溶剂
  • 制备用于溶栓研究的低温敏感脂质体

Biochem/physiol Actions

磷脂酰胆碱(PC)通过充当表面活性剂在粘液中形成疏水表面,从而抑制细菌的渗透。

Packaging

5 mL棕色玻璃螺旋盖小瓶(850446P-200mg)
5 mL棕色玻璃螺旋盖小瓶(850446P-25mg)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC


Still not finding the right product?

Explore all of our products under 14:0-18:0 PC


存储类别

11 - Combustible Solids



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Inflammatory Bowel Disease
Integrative Medicine, 501-516 (2018)
Vishal Saxena et al.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 31(1), 67-73 (2015-03-15)
Clinical efficacy of thrombolytic drugs is limited by lack of specific delivery and requires large therapeutic doses which increase toxicity. Encapsulating these drugs in temperature-sensitive liposomes and applying hyperthermia to deliver thrombolytic agents locally to thrombus might theoretically favourably alter
M Habib Ali et al.
International journal of pharmaceutics, 453(1), 225-232 (2012-07-07)
Liposomes are well recognised for their ability to improve the delivery of a range of drugs. More commonly they are applied for the delivery of water-soluble drugs, but given their structural attributes, they can also be employed as solubilising agents



全球贸易项目编号

货号GTIN
850446P-200MG04061835230808
850446P-25MG04061835230815